文献速递主动脉疾病

腹膜后血肿体积是破裂性腹主动脉瘤腔内修复术后围手术期死亡的良好预测指标

Retroperitoneal hematoma volume is a good predictor of perioperative mortality after endovascular aneurysm repair for ruptured abdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2018-01-01

该研究回顾性分析了2012至2016年日本三家参与机构中连续接受统一EVAR优先方案的破裂性腹主动脉瘤患者,最终82例纳入分析。结果显示腹膜后血肿体积比值在存活者与死亡者间差异显著,且在Fitzgerald分型>III的患者中预测价值最佳,最佳截断值为6.97%。

要点

  • 腹膜后血肿体积比值在存活者与死亡者间差异显著(3.59%±2.46% vs 7.63%±3.45%,P<.001)。
  • 在Fitzgerald分型>III的患者中,腹膜后血肿体积比值的AUC为0.880,优于Glasgow Aneurysm Score的0.587。
  • 最佳截断值6.97%对应敏感度0.833、特异度0.860。

核心结论

  • 研究表明腹膜后血肿体积可能是EVAR治疗rAAA后围手术期死亡的良好预测指标,尤其对Fitzgerald分型>III的患者,最佳截断值为6.97%。

研究设计与样本

  • 回顾性审查了2012至2016年在日本三家参与机构中连续接受统一EVAR优先方案的rAAA患者,并前瞻性注册于专用数据库。
  • 仅纳入术前CT扫描适合三维体积分析的82例EVAR治疗患者。

主要发现

  • 114例rAAA患者中,101例(88.6%)接受EVAR,9例(7.9%)接受开放手术修复,4例(3.5%)未接受任何修复。
  • 纳入分析的82例与排除的19例患者30天死亡率分别为24.4%和31.6%,差异无统计学意义(P=.518)。
  • 腹膜后血肿体积比值在存活者为3.59%±2.46%,死亡者为7.63%±3.45%(P<.001)。
  • 单因素分析显示Glasgow Aneurysm Score>85、收缩压<90 mm Hg、意识丧失及平均最小右髂外动脉直径有统计学意义。
  • 在Fitzgerald分型>III的患者中,腹膜后血肿体积比值预测围手术期死亡的AUC为0.880,Glasgow Aneurysm Score的AUC为0.587(P<.001)。

关键数值与推荐

  • 腹膜后血肿体积比值最佳截断值为6.97%,敏感度0.833,特异度0.860。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to validate the usefulness of retroperitoneal hematoma volume as a predictor of perioperative mortality after endovascular aneurysm repair (EVAR) for ruptured abdominal aortic aneurysm (rAAA). METHODS: We retrospectively reviewed consecutive patients with rAAA who underwent the unified EVAR first protocol between 2012 and 2016 at any one of three participating institutions in Japan and were prospectively registered in a dedicated database. Only patients with preoperative computed tomography scans adequate for three-dimensional volumetric analysis were included. Volumetry was used to measure the retroperitoneal hematoma volume. To adjust for body size differences between patients, the retroperitoneal hematoma volume was divided by the abdominal cavity volume, and the predictive power of this ratio was validated using appropriate statistical methods. RESULTS: Of 114 patients with rAAA managed during the study period, 101 (88.6%) underwent EVAR, 9 (7.9%) underwent open surgical repair, and 4 (3.5%) did not undergo any repair. Finally, 82 of 101 patients treated with EVAR were included in the analysis. Within 30 days after EVAR, the mortality rates for the 82 patients included in the analysis and the 19 excluded patients were 24.4% and 31.6%, respectively, without statistically significant differences (P = .518). The retroperitoneal hematoma volume ratio was 3.59% ± 2.46% and 7.63% ± 3.45% in survivors and nonsurvivors, respectively (P < .001). Univariate analysis of other preoperative demographic and anatomic factors revealed that a Glasgow Aneurysm Score >85, systolic blood pressure <90 mm Hg, loss of consciousness, and mean minimum right external iliac artery diameter were statistically significant. Receiver operating characteristic curve analysis for the prediction of perioperative mortality revealed that retroperitoneal hematoma volume ratio was the best predictor of perioperative mortality in patients with rAAA of type >III in the Fitzgerald classification (area under the curve: retroperitoneal hematoma volume ratio, 0.880; Glasgow Aneurysm Score, 0.587; P < .001). Based on the Youden index, the optimal cutoff for the retroperitoneal hematoma volume ratio was 6.97%, providing a sensitivity of 0.833 and specificity of 0.860. CONCLUSIONS: Our study suggests that retroperitoneal hematoma volume may be a good predictor of perioperative mortality after EVAR for rAAA, especially for patients with Fitzgerald classification >III and a best cutoff value of 6.97%.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fujimura N, Takahara M, Isogai N, et al. Retroperitoneal hematoma volume is a good predictor of perioperative mortality after endovascular aneurysm repair for ruptured abdominal aortic aneurysm. J Vasc Surg. 2018. PMID: 29685516. doi:10.1016/j.jvs.2018.01.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。